This inventor holds 1 USPTO granted patent and 4 published patent applications, plus 1 CIPO patent. Top assignee: Glaxosmithkline LLC. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Christopher John Burns: Innovator in Pharmaceutical Compounds
Introduction
Christopher John Burns is a notable inventor based in Caulfield North, Australia. He has made significant contributions to the field of pharmaceuticals, particularly with his innovative work on phenyl amino pyrimidine compounds. His expertise and dedication to research have led to the development of valuable intellectual property.
Latest Patents
Christopher holds a patent for "Phenyl Amino Pyrimidine Compounds and Uses Thereof." This patent represents his commitment to advancing pharmaceutical science and improving therapeutic options available in the market. He has successfully secured 1 patent that showcases his inventive capabilities.
Career Highlights
Christopher is currently employed at GlaxoSmithKline LLC, a leading global healthcare company. His role at GlaxoSmithKline allows him to collaborate with other talented professionals in the industry and contribute to groundbreaking research and development projects.
Collaborations
Some of Christopher's coworkers include Thao Lien Thi Nguyen and John Thomas Feutrill. Their collaborative efforts in research and development have further enhanced the innovative environment at GlaxoSmithKline.
Conclusion
Christopher John Burns is a distinguished inventor whose work in pharmaceutical compounds has made a significant impact. His patent and contributions to GlaxoSmithKline reflect his dedication to advancing healthcare solutions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile